These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27644893)

  • 1. Melatonin pharmacokinetics after transdermal administration changes according to the time of the day.
    Flo A; Cambras T; Díez-Noguera A; Calpena A
    Eur J Pharm Sci; 2017 Jan; 96():164-170. PubMed ID: 27644893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Safety of Intravenous, Intravesical, Rectal, Transdermal, and Vaginal Melatonin in Healthy Female Volunteers: A Cross-Over Study.
    Zetner D; Andersen LPK; Alder R; Jessen ML; Tolstrup A; Rosenberg J
    Pharmacology; 2021; 106(3-4):169-176. PubMed ID: 32937627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal absorption of melatonin in vivo bioavailability study.
    Bechgaard E; Lindhardt K; Martinsen L
    Int J Pharm; 1999 May; 182(1):1-5. PubMed ID: 10332069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review.
    Zetner D; Andersen LP; Rosenberg J
    Drug Res (Stuttg); 2016 Apr; 66(4):169-73. PubMed ID: 26514093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers.
    Andersen LP; Werner MU; Rosenkilde MM; Harpsøe NG; Fuglsang H; Rosenberg J; Gögenur I
    BMC Pharmacol Toxicol; 2016 Feb; 17():8. PubMed ID: 26893170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems.
    Priano L; Esposti D; Esposti R; Castagna G; De Medici C; Fraschini F; Gasco MR; Mauro A
    J Nanosci Nanotechnol; 2007 Oct; 7(10):3596-601. PubMed ID: 18330178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absolute bioavailability of oral melatonin.
    DeMuro RL; Nafziger AN; Blask DE; Menhinick AM; Bertino JS
    J Clin Pharmacol; 2000 Jul; 40(7):781-4. PubMed ID: 10883420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of melatonin starch microspheres.
    Mao S; Chen J; Wei Z; Liu H; Bi D
    Int J Pharm; 2004 Mar; 272(1-2):37-43. PubMed ID: 15019067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications.
    Yeleswaram K; McLaughlin LG; Knipe JO; Schabdach D
    J Pineal Res; 1997 Jan; 22(1):45-51. PubMed ID: 9062870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin.
    Fourtillan JB; Brisson AM; Gobin P; Ingrand I; Decourt JP; Girault J
    Biopharm Drug Dispos; 2000 Jan; 21(1):15-22. PubMed ID: 11038434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection.
    Mallo C; Zaĭdan R; Galy G; Vermeulen E; Brun J; Chazot G; Claustrat B
    Eur J Clin Pharmacol; 1990; 38(3):297-301. PubMed ID: 2340850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
    Cho CW; Choi JS; Yang KH; Shin SC
    Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Repeated Melatonin Drug Administrations Prior to and After Surgery.
    Harpsøe NG; Andersen LP; Mielke LV; Jønsson B; Jenstrup MT; Gögenur I; Rosenberg J
    Clin Drug Investig; 2016 Dec; 36(12):1045-1050. PubMed ID: 27566320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of orally administered melatonin in critically ill patients.
    Mistraletti G; Sabbatini G; Taverna M; Figini MA; Umbrello M; Magni P; Ruscica M; Dozio E; Esposti R; DeMartini G; Fraschini F; Rezzani R; Reiter RJ; Iapichino G
    J Pineal Res; 2010 Mar; 48(2):142-7. PubMed ID: 20070489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.
    Carroll GL; Hooper RN; Boothe DM; Hartsfield SM; Randoll LA
    Am J Vet Res; 1999 Aug; 60(8):986-91. PubMed ID: 10451210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of oral melatonin in humans.
    Waldhauser F; Waldhauser M; Lieberman HR; Deng MH; Lynch HJ; Wurtman RJ
    Neuroendocrinology; 1984 Oct; 39(4):307-13. PubMed ID: 6493445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin.
    Bénès L; Claustrat B; Horrière F; Geoffriau M; Konsil J; Parrott KA; DeGrande G; McQuinn RL; Ayres JW
    J Pharm Sci; 1997 Oct; 86(10):1115-9. PubMed ID: 9344167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes.
    Dubey V; Mishra D; Asthana A; Jain NK
    Biomaterials; 2006 Jun; 27(18):3491-6. PubMed ID: 16513163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.